-
Something wrong with this record ?
Interactions Among Polymorphisms of Susceptibility Loci for Alzheimer's Disease or Depressive Disorder
E. Kitzlerová, Z. Fišar, P. Lelková, R. Jirák, M. Zvěřová, J. Hroudová, A. Manukyan, P. Martásek, J. Raboch,
Language English Country United States
Document type Journal Article
NLK
PubMed Central
from 2011
Europe PubMed Central
from 2011
Open Access Digital Library
from 2011-01-01
Medline Complete (EBSCOhost)
from 2017-01-01
PubMed
29703883
DOI
10.12659/msm.907202
Knihovny.cz E-resources
- MeSH
- Alleles MeSH
- Alzheimer Disease genetics MeSH
- Demography MeSH
- Depressive Disorder, Major genetics MeSH
- Gene Frequency MeSH
- Epistasis, Genetic * MeSH
- Genetic Predisposition to Disease * MeSH
- Genetic Association Studies MeSH
- Genetic Loci * MeSH
- Polymorphism, Single Nucleotide genetics MeSH
- Middle Aged MeSH
- Humans MeSH
- Polymorphism, Genetic * MeSH
- Aged MeSH
- Case-Control Studies MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
BACKGROUND Several genetic susceptibility loci for major depressive disorder (MDD) or Alzheimer's disease (AD) have been described. Interactions among polymorphisms are thought to explain the differences between low- and high-risk groups. We tested for the contribution of interactions between multiple functional polymorphisms in the risk of MDD or AD. MATERIAL AND METHODS A genetic association case-control study was performed in 68 MDD cases, 84 AD cases (35 of them with comorbid depression), and 90 controls. The contribution of 7 polymorphisms from 5 genes (APOE, HSPA1A, SLC6A4, HTR2A, and BDNF) related to risk of MDD or AD development was analyzed. RESULTS Significant associations were found between MDD and interactions among polymorphisms in HSPA1A, SLC6A4, and BDNF or HSPA1A, BDNF, and APOE genes. For polymorphisms in the APOE gene in AD, significant differences were confirmed on the distributions of alleles and genotype rates compared to the control or MDD. Increased probability of comorbid depression was found in patients with AD who do not carry the ε4 allele of APOE. CONCLUSIONS Assessment of the interactions among polymorphisms of susceptibility loci in both MDD and AD confirmed a synergistic effect of genetic factors influencing inflammatory, serotonergic, and neurotrophic pathways at these heterogenous complex diseases. The effect of interactions was greater in MDD than in AD. A presence of the ε4 allele was confirmed as a genetic susceptibility factor in AD. Our findings indicate a role of APOE genotype in onset of comorbid depression in a subgroup of patients with AD who are not carriers of the APOE ε4 allele.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19000779
- 003
- CZ-PrNML
- 005
- 20190122121229.0
- 007
- ta
- 008
- 190107s2018 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.12659/MSM.907202 $2 doi
- 035 __
- $a (PubMed)29703883
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Kitzlerová, Eva $u Department of Psychiatry, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
- 245 10
- $a Interactions Among Polymorphisms of Susceptibility Loci for Alzheimer's Disease or Depressive Disorder / $c E. Kitzlerová, Z. Fišar, P. Lelková, R. Jirák, M. Zvěřová, J. Hroudová, A. Manukyan, P. Martásek, J. Raboch,
- 520 9_
- $a BACKGROUND Several genetic susceptibility loci for major depressive disorder (MDD) or Alzheimer's disease (AD) have been described. Interactions among polymorphisms are thought to explain the differences between low- and high-risk groups. We tested for the contribution of interactions between multiple functional polymorphisms in the risk of MDD or AD. MATERIAL AND METHODS A genetic association case-control study was performed in 68 MDD cases, 84 AD cases (35 of them with comorbid depression), and 90 controls. The contribution of 7 polymorphisms from 5 genes (APOE, HSPA1A, SLC6A4, HTR2A, and BDNF) related to risk of MDD or AD development was analyzed. RESULTS Significant associations were found between MDD and interactions among polymorphisms in HSPA1A, SLC6A4, and BDNF or HSPA1A, BDNF, and APOE genes. For polymorphisms in the APOE gene in AD, significant differences were confirmed on the distributions of alleles and genotype rates compared to the control or MDD. Increased probability of comorbid depression was found in patients with AD who do not carry the ε4 allele of APOE. CONCLUSIONS Assessment of the interactions among polymorphisms of susceptibility loci in both MDD and AD confirmed a synergistic effect of genetic factors influencing inflammatory, serotonergic, and neurotrophic pathways at these heterogenous complex diseases. The effect of interactions was greater in MDD than in AD. A presence of the ε4 allele was confirmed as a genetic susceptibility factor in AD. Our findings indicate a role of APOE genotype in onset of comorbid depression in a subgroup of patients with AD who are not carriers of the APOE ε4 allele.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a alely $7 D000483
- 650 _2
- $a Alzheimerova nemoc $x genetika $7 D000544
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a demografie $7 D003710
- 650 _2
- $a depresivní porucha unipolární $x genetika $7 D003865
- 650 12
- $a genetická epistáze $7 D004843
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a frekvence genu $7 D005787
- 650 _2
- $a genetické asociační studie $7 D056726
- 650 12
- $a genetické lokusy $7 D056426
- 650 12
- $a genetická predispozice k nemoci $7 D020022
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a polymorfismus genetický $7 D011110
- 650 _2
- $a jednonukleotidový polymorfismus $x genetika $7 D020641
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Fišar, Zdeněk $u Department of Psychiatry, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
- 700 1_
- $a Lelková, Petra $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
- 700 1_
- $a Jirák, Roman $u Department of Psychiatry, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
- 700 1_
- $a Zvěřová, Martina $u Department of Psychiatry, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
- 700 1_
- $a Hroudová, Jana $u Department of Psychiatry, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
- 700 1_
- $a Manukyan, Ada $u Department of Psychiatry, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
- 700 1_
- $a Martásek, Pavel $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
- 700 1_
- $a Raboch, Jiří $u Department of Psychiatry, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
- 773 0_
- $w MED00003251 $t Medical science monitor international medical journal of experimental and clinical research $x 1643-3750 $g Roč. 24, č. - (2018), s. 2599-2619
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29703883 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190107 $b ABA008
- 991 __
- $a 20190122121449 $b ABA008
- 999 __
- $a ok $b bmc $g 1363921 $s 1038902
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 24 $c - $d 2599-2619 $e 20180428 $i 1643-3750 $m Medical Science Monitor $n Med Sci Monit $x MED00003251
- LZP __
- $a Pubmed-20190107